Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 Diabetes
Clinical trial NCT02060916 · COMPLETED
Trial details
- NCT number
- NCT02060916
- Sponsor
- Boston Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2011-08-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.